Walgreens announced that it is expanding its specialty pharmacy offerings. Experts think that this move could yield several strategic benefits, given the higher profit margins associated with specialty medications compared to traditional drugs. They also think Walgreens' move could lead to greater competition, consolidation and innovation within the broader pharmacy industry.
Time is running out! Secure your spot at the premier healthcare investment event in Chicago on May 21-22. Network with industry leaders, discover groundbreaking startups, and explore the latest trends.
Don't miss this exclusive opportunity to save $100 – offer ends TONIGHT!
If you advise self-insured employers on healthcare benefits, your expert insights will help provide a comprehensive perspective of the state of healthcare benefits for employers in our second annual survey, the 2024 Benefit Consultant Sentiment THE INDEX.
Regeneron Pharmaceuticals is collaborating with CRISPR technologies startup Mammoth Biosciences to develop in vivo gene-editing therapies. The deal marks the third pharmaceutical industry partnership for Mammoth, which initially focused on developing CRISPR-based diagnostics.
In this month's episode, we talk about the massive cyberattack at Change Healthcare that brought the healthcare payment processing clearinghouse to its knees. How were providers, patients, pharmacies, and health systems affected? We also talk about 23AndMe and its relevance in the marketplace. Finally, as a journalist and investor, we offer advice to startups on what is a turn-off for us.
No comments